Once daily dosing of 3g mesalamaine (Salofalk (R) granules) is therapeutic equivalent to a three-times daily dosing of 1g mesalamine for the treatment of active ulcerative colitis

W Kruis, A Gorelov, G Kiudelis, I Racz, J Pokrotnieks, M Horynski, M Batovsky, J Kykal, D Keret, R Greinwald, R Mueller

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Article number898
Pages (from-to)A130-A131
Issue number4, Suppl.2
Publication statusPublished - Apr 2007
Externally publishedYes
EventMeeting of the American Society for Gastrointestinal Endoscopy (ASGE) "Digestive Disease Week" - Washington, United States
Duration: 19 May 200724 May 2007

Field of Science*

  • 3.2 Clinical medicine

Publication Type*

  • 3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Cite this